Cargando…
Dronedarone for atrial fibrillation: a new therapeutic agent
Atrial fibrillation is the most common of the serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality. Amiodarone is currently one of the most widely used and most effective antiarrhythmic agents for atrial fibrillation. But during chronic usage amiodarone can...
Autores principales: | Patel, Pawan D, Bhuriya, Rohit, Patel, Dipal D, Arora, Bhaskar L, Singh, Param P, Arora, Rohit R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725796/ https://www.ncbi.nlm.nih.gov/pubmed/19688104 |
Ejemplares similares
-
Dronedarone in the management of atrial fibrillation
por: Saleem, TS Mohamed, et al.
Publicado: (2010) -
Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013) -
Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011) -
Management of atrial fibrillation: focus on the role of dronedarone
por: Cheng, Judy WM
Publicado: (2011) -
Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation
por: Sullivan, Renee M, et al.
Publicado: (2010)